Read the findings & sources
Preclinical evidenceThe original MOTS-c study linked this mitochondrial-derived peptide to metabolic signaling in cells and mice. In high-fat-diet mouse experiments, researchers reported improved insulin sensitivity and protection against diet-related metabolic changes. These animal findings do not quantify human weight loss or demonstrate improved exercise capacity from administering MOTS-c to people.

